Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NEORX(nerx) -- Ignore unavailable to you. Want to Upgrade?

To: peat who wrote (566)	1/19/2000 12:24:00 PM
From: OldAIMGuy	Respond to of 661

Hi Peat (Pete?), I had some very old shares in the account that were at a significant loss and sold those before the end of 1999. The remaining shares are pretty cheap - probably under $2.00/share. I guess it would be nice to have those other shares now, but it was also nice to have at least one loss for the year! :-) The whole bio world seems to be taking on improved respect. NERX's current project is moving along nicely and looks quite promising. This holding is finally after a long time back in the black for me overall. At $6+ it's showing a 36% profit. Not great for all the years that I've held it, but then this isn't exactly the base of my investment pyramid, either. I own the Common and the Preferred. I've known too many people who have had various cancers spread to the bone. Let's hope this therapy can be developed fully. Best regards, Tom